fda retatrutide approval status 2025 Eli Lilly gave mysterious access to weight loss drug to 79-year-old patient Can You Access Retatrutide Before

doi: 10.1016/j.ecoenv.2025.118080 24

Thyroid C-cell precautionary warning in line with GLP-1 class: Personal or family history of medullary thyroid carcinoma is a contraindication that any responsible physician screens for before prescribing, based on the same precautionary signals seen across this drug class in animal studies

He Y, Sawalha AH

Essential documentation includes: Prescription/Pharmacy records to confirm drug exposure

Women may experience distinct benefits and side effects, yet research gaps, especially in females, persist

They told us what they want patients to know about how these drugs work, who will benefit from them and what the science says about their long-term use